Category: Drug Development
Drug Development market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Liposomal Doxorubicin
The 2025-2030 World Outlook for Liposomal Doxorubicin This study covers the world outlook for liposomal doxorubicin across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Natural Killer Cell Therapeutics
The 2025-2030 World Outlook for Natural Killer Cell Therapeutics This study covers the world outlook for natural killer cell therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More
-
The 2025-2030 World Outlook for Cloud-Based Drug Discovery Platforms
The 2025-2030 World Outlook for Cloud-Based Drug Discovery Platforms This study covers the world outlook for cloud-based drug discovery platforms across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the countr ... Read More
-
The 2025-2030 World Outlook for Viral Clearance of Recombinant Proteins
The 2025-2030 World Outlook for Viral Clearance of Recombinant Proteins This study covers the world outlook for viral clearance of recombinant proteins across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ... Read More
-
The 2025-2030 World Outlook for Mutation-Suppression Duchenne Muscular Dystrophy Drugs
The 2025-2030 World Outlook for Mutation-Suppression Duchenne Muscular Dystrophy Drugs This study covers the world outlook for mutation-suppression Duchenne muscular dystrophy drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indust ... Read More
-
The 2025-2030 World Outlook for Neuroendocrine Tumors
The 2025-2030 World Outlook for Neuroendocrine Tumors This study covers the world outlook for neuroendocrine tumors across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Immunology Drugs
The 2025-2030 World Outlook for Immunology Drugs This study covers the world outlook for immunology drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
-
The 2025-2030 World Outlook for Cancer-Treating Drugs
The 2025-2030 World Outlook for Cancer-Treating Drugs This study covers the world outlook for cancer-treating drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for RNA-Based Therapeutics
The 2025-2030 World Outlook for RNA-Based Therapeutics This study covers the world outlook for RNA-based therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Cancer Immunotherapy Drug Discovery Outsourcing
The 2025-2030 World Outlook for Cancer Immunotherapy Drug Discovery Outsourcing This study covers the world outlook for cancer immunotherapy drug discovery outsourcing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P ... Read More
-
The 2025-2030 World Outlook for Small Molecule Drug Discovery Technologies
The 2025-2030 World Outlook for Small Molecule Drug Discovery Technologies This study covers the world outlook for small molecule drug discovery technologies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ... Read More
-
The 2025-2030 World Outlook for Small Molecule Apis
The 2025-2030 World Outlook for Small Molecule Apis This study covers the world outlook for small molecule apis across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Thin Film Drugs
The 2025-2030 World Outlook for Thin Film Drugs This study covers the world outlook for thin film drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars ... Read More
-
The 2025-2030 World Outlook for Smart Pills
The 2025-2030 World Outlook for Smart Pills This study covers the world outlook for smart pills across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the p ... Read More
-
The 2025-2030 World Outlook for Trastuzumab
The 2025-2030 World Outlook for Trastuzumab This study covers the world outlook for trastuzumab across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the p ... Read More
-
The 2025-2030 World Outlook for Oncology Small Molecule Drug Discovery
The 2025-2030 World Outlook for Oncology Small Molecule Drug Discovery This study covers the world outlook for oncology small molecule drug discovery across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the co ... Read More
-
The 2025-2030 World Outlook for Oncolytic Virus Immunotherapies
The 2025-2030 World Outlook for Oncolytic Virus Immunotherapies This study covers the world outlook for oncolytic virus immunotherapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Therapeutic Automation
The 2025-2030 World Outlook for Therapeutic Automation This study covers the world outlook for therapeutic automation across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Immunotherapy Cancer Drugs
The 2025-2030 World Outlook for Immunotherapy Cancer Drugs This study covers the world outlook for immunotherapy cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for RNA Therapeutics
The 2025-2030 World Outlook for RNA Therapeutics This study covers the world outlook for RNA therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
-
The 2025-2030 World Outlook for Metabolomics Technologies
The 2025-2030 World Outlook for Metabolomics Technologies This study covers the world outlook for metabolomics technologies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
-
The 2025-2030 World Outlook for Checkpoint Inhibitors
The 2025-2030 World Outlook for Checkpoint Inhibitors This study covers the world outlook for checkpoint inhibitors across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Sequencing and Target Data Analysis Drug Discovery Informatics
The 2025-2030 World Outlook for Sequencing and Target Data Analysis Drug Discovery Informatics This study covers the world outlook for sequencing and target data analysis drug discovery informatics across more than 190 countries. For each year reported, estimates are given for the latent demand, or ... Read More
-
The 2025-2030 World Outlook for Cloud-Based Drug Discovery Platforms for Pharmaceutical Vendors
The 2025-2030 World Outlook for Cloud-Based Drug Discovery Platforms for Pharmaceutical Vendors This study covers the world outlook for cloud-based drug discovery platforms for pharmaceutical vendors across more than 190 countries. For each year reported, estimates are given for the latent demand, o ... Read More
-
The 2025-2030 World Outlook for Preclinical Imaging (In-VIVO)
The 2025-2030 World Outlook for Preclinical Imaging (In-VIVO) This study covers the world outlook for preclinical imaging (in-VIVO) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More
Research Assistance
